Axel Goetz, MD, PhD, is chief science officer of RealAge and is a member of the RealAge Scientific Advisory Board.

Following his medical training and a doctoral program in physiology at the University of Tuebingen in Germany, Dr. Goetz earned his PhD in experimental psychology of human learning and information processing at Iowa State University. As a faculty member of the Southern Illinois University School of Medicine, he helped develop and evaluate the school's initial curriculum and chaired the Curriculum Self-Study Committee for the school's accreditation. Dr. Goetz cofounded General Health, Inc., which became the leading company in health risk measurement and management. He was responsible for research, development, and quality control of its products and services. While at GHI, he was a principal of the Risk Factor Update Project for the Centers for Disease Control. He assembled and chaired the Scientific Advisory Committee for the Health Risk Appraisal Project of the Carter Presidential Center at Emory University. The Society of Prospective Medicine granted him its highest honor, the Lewis C. Robbins Award, for Outstanding Service in the Advancement of Useful Life Expectancy. Dr. Goetz returned to RealAge as medical director in January 2004, after working two-and-a half years as principal scientist with the Health Group of Exponent, Inc.